Legal

GlaxoSmithKline is facing serious charges of misconduct as enforcement grows fierce. The entwining Chinese anti-bribery laws, the US FCPA and UK Bribery Act call for immediate attention to risks and compliance on both a national and global scale

GlaxoSmithKline is facing serious charges of misconduct as enforcement grows fierce. The entwining Chinese anti-bribery laws, the US FCPA and UK Bribery Act call for immediate attention to risks and compliance on both a national and global scale

After five years, MOFCOM has updated its merger control notification rules. Although big improvements have been made, issues with determining control and new joint venture turnovers still need clarification

After five years, MOFCOM has updated its merger control notification rules. Although big improvements have been made, issues with determining control and new joint venture turnovers still need clarification

Many foreign companies are being attacked by Chinese companies for payment under guarantee fraud claims. Peng Shen and Ying Wu explain how devising a comprehensive dispute resolution strategy is key to avoid and manage these risks

SAFE has relaxed its control over foreign exchange for cross-border security. Yun Chen believes the new rules are an important breakthrough for onshore and offshore financing

The CSRC has simplified M&A and asset restructurings of unlisted public companies and the PBOC has reduced conditions for banks' settling and selling foreign exchange

This week Swiss companies enjoyed tariff cuts in China, the Supreme People's Court bolstered its Environmental and Resources Tribunal and Hugo Boss followed luxury group trends in direct store ownership

An acquirer may control two insurance companies that engage in the same type of business.